Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-16

FDA Approved: SOTYLIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for SOTYLIZE (sotalol hydrochloride) from Azurity Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOTYLIZE (Sotalol hydrochloride)

Snippet

SUPPL AP for SOTYLIZE (SOTALOL HYDROCHLORIDE)